论文部分内容阅读
作者采用多中心、随机、双盲法,对以1型人类免疫缺陷症病毒(HIV-1)LAV株gp160重组痘苗活病毒初免、再用杆状病毒表达的HIV-ILAV重组gp16O候选疫苗加强免疫所诱生的能识别感染细胞表面表达的天然外膜糖蛋白的抗体进行了测定.
The authors used a multicenter, randomized, double-blind trial of HIV-ILAV recombinant gp16O vaccine candidate that was immunized with the recombinant vaccinia virus gp160 from the human immunodeficiency virus type 1 (HIV-1) LAV strain and then expressed with baculovirus Antibody induced by immunization that recognizes native outer membrane glycoprotein expressed on the surface of infected cells was assayed.